首页> 外文OA文献 >Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin Lymphoma

【2h】

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin Lymphoma

机译：在中枢和高级非霍奇金淋巴瘤自体造血干细胞移植中使用药物动力学指导静脉白硫烷，环磷酰胺和依托泊苷制备方案的10年单中心经验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Patil Neha R.; Salzman Donna; Donnellan William; Vaughan William;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen. [J] . Aggarwal C, Gupta S, Vaughan WP, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第7期

机译：自体造血干细胞移植在白消安，环磷酰胺和依托泊苷制备方案中用口服白消安替代静脉内自体造血干细胞移植后，中，高危侵袭性非霍奇金淋巴瘤的预后得到改善。
2. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma. [J] . Kim JG, Sohn SK, Chae YS, Bone marrow transplantation . 2007,第10期

机译：对非霍奇金淋巴瘤患者自体干细胞移植进行调理方案的静脉注射白消安，环磷酰胺和依托泊苷（i.v. Bu / Cy / E）的多中心研究。
3. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience. [J] . Ulrickson M, Aldridge J, Kim HT Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2009,第11期

机译：非人霍奇金淋巴瘤患者中自体干细胞移植的制备方案为白消安和环磷酰胺（Bu / Cy）：单机构经验。
4. HIGH DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDM/SCT) FOR TREATMENT OF AL AMYLOIDOSIS: TEN YEAR SINGLE INSTITUTIONAL EXPERIENCE [C] . D. C. Setdin, V. Sanchorawala, K. Malek, International Symposium on Amyloidosis . 2005

机译：高剂量素母蛋白和自体干细胞移植（HDM / SCT）用于治疗Al淀粉样症：十年单一制度经验
5. Efficacy of Pharmacokinetics-Directed Busulfan Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes [O] . Christopher R. Flowers, Luciano J. Costa, Marcelo C Pasquini, -1

机译：药代动力学指导的白消安环磷酰胺和依托泊苷的调理作用以及自体干细胞移植治疗淋巴瘤的有效性：多中心2期研究和CIBMTR结果的比较
6. Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen [O] . Aggarwal Charu, Gupta Sameer, Vaughan William P., 2006

机译：自体造血干细胞移植取代静脉注射白消安，环磷酰胺和依托泊苷制备方案后，自体造血干细胞移植后中，高危侵袭性非霍奇金淋巴瘤的改善结果

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin Lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅